List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 48 studies with search of:   "Warts"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Recruiting Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: Comparator: GARDASIL(R);   Biological: Comparator: V503
22 Active, not recruiting A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: V504;   Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Placebo (unspecified)
23 Active, not recruiting Broad Spectrum HPV (Human Papillomavirus) Vaccine (V505) in 16 to 26 Year Old Women
Conditions: Cervical Cancer;   Vulvar Cancer;   Vaginal Cancer;   Genital Warts;   Human Papillomavirus Infection
Interventions: Biological: V505;   Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Comparator: Placebo (unspecified)
24 Active, not recruiting An Investigational Study of Gardasil (V501) in Reducing the Incidence of Anogenital Warts in Young Men
Condition: Condylomata Acuminata
Interventions: Biological: (Gardasil) human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Biological: Comparator: placebo (unspecified)
25 Completed Study to Test the Safety of HPV Vaccine in Women
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine / Duration of Treatment : 4 Years;   Biological: Comparator: placebo (concomitant-vaccine matched) / Duration of Treatment : 4 Years
26 Completed Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years
27 Completed A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: HPV (Human Papillomavirus) Vaccine
28 Completed Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 4 years
29 Completed Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)
Conditions: Cervical Cancer;   Genital Warts
Intervention: Biological: V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine / Duration of Treatment: 7 months
30 Completed Broad Spectrum HPV Vaccine Dose Ranging Study
Conditions: HPV;   Cervical Cancer;   Premalignancy Anogenital Warts
Interventions: Biological: Comparator: Gardasil;   Biological: Comparator: octavalent HPV Vaccine - dose formulation 1;   Biological: Comparator: octavalent HPV Vaccine - dose formulation 2;   Biological: Comparator: octavalent HPV Vaccine - dose formulation 3
31 Recruiting Treatment of Oral Warts in HIV+ Patients
Conditions: Papillomatosis;   HIV Infections
Interventions: Drug: interferon-alpha lozenges;   Drug: placebo
32 Completed PDT With Metvix® 160 mg/g Cream in Organ Transplant Recipients With Non-Melanoma Skin Cancer
Conditions: Actinic Keratosis;   Warts;   Basal Cell Carcinoma;   Bowens Disease;   Squamous Cell Carcinoma
Intervention: Procedure: Photodynamic therapy with Metvix 160 mg/g cream
33 Completed The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients
Conditions: HIV Infections;   Condyloma Acuminata
Intervention: Drug: Cidofovir
34 Terminated Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study
Conditions: Cervical Cancer;   Condylomata Acuminata
Intervention: Biological: V502
35 Completed Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
Condition: Papilloma
Intervention: Drug: Cidofovir
36 Active, not recruiting A Single Centre Study to Evaluate the Safety and Immunogenicity of the HPV Vaccine (GSK-580299) in Chinese Females
Condition: Human Papillomavirus Infection
Intervention: Biological: HPV vaccine (GSK-580299)
37 Recruiting The Human Papillomavirus (HPV) Transmission Pilot Study
Condition: Human Papillomavirus Infection
Intervention:
38 Recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-Related Malignancies;   Lymphoma;   Multicentric Castleman Disease;   Precancerous/Nonmalignant Condition;   Sarcoma
Interventions: Procedure: colposcopic biopsy;   Procedure: cytology specimen collection procedure;   Procedure: histological technique;   Procedure: laboratory biomarker analysis;   Procedure: polymerase chain reaction
39 Completed A Trial Investigating the Effect of a Treatment With Zinkgluconaat for Verrucae Vulgares
Condition: Verrucae Vulgares
Intervention: Drug: Administration of zinkgluconaat or placebo
40 Active, not recruiting Randomized Trial of Alternative HPV Vaccination Schedules in a University Setting
Condition: Human Papillomavirus Infection
Interventions: Biological: Quadrivalent human papillomavirus vaccine;   Biological: Quadrivalent human papillomavirus vaccine

Previous Page (1-20) Studies Shown (21-40) Next (41-48)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services